Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
General Discussion
Related: Editorials & Other Articles, Issue Forums, Alliance Forums, Region ForumsDrug companies are sitting on generics--43% of recently approved aren't for sale
You pay more for medicine because hundreds of generics aren't for sale.BETH MOLE - 2/8/2019, 3:50 PM
Of the more than 1,600 generic drugs approved by the Food and Drug Administration since January of 2017, more than 700or 43 percentare not for sale in the US, according to a new analysis by Kaiser Health News.
The finding means that many pricy, brand-name drugs are not facing the competition that could help drive down soaring prices. Among the drugs missing in action are generic versions of the expensive blood thinner Brilinta and the HIV medication Truvada. Moreover, of the approved drugs that would offer a brand-name drug its first competition, 36 percent are being held off the market, the analysis found.
Experts told KHN that the reasons drug makers may withhold an approved generic from the market are varied. Industry consolidation has made buying, manufacturing, and distributing generics more difficult in recent years. Generic drug makers also, as always, face patent litigation from brand-name makers. Then theres potentially anti-competitive deals, in which brand-name drug makers simply pay generic makers to keep their product off the market for a whilea so-called pay for delay tactic.
The finding means that many pricy, brand-name drugs are not facing the competition that could help drive down soaring prices. Among the drugs missing in action are generic versions of the expensive blood thinner Brilinta and the HIV medication Truvada. Moreover, of the approved drugs that would offer a brand-name drug its first competition, 36 percent are being held off the market, the analysis found.
Experts told KHN that the reasons drug makers may withhold an approved generic from the market are varied. Industry consolidation has made buying, manufacturing, and distributing generics more difficult in recent years. Generic drug makers also, as always, face patent litigation from brand-name makers. Then theres potentially anti-competitive deals, in which brand-name drug makers simply pay generic makers to keep their product off the market for a whilea so-called pay for delay tactic.
https://arstechnica.com/science/2019/02/drug-companies-are-sitting-on-generics-43-of-recently-approved-arent-for-sale/
InfoView thread info, including edit history
TrashPut this thread in your Trash Can (My DU » Trash Can)
BookmarkAdd this thread to your Bookmarks (My DU » Bookmarks)
5 replies, 593 views
ShareGet links to this post and/or share on social media
AlertAlert this post for a rule violation
PowersThere are no powers you can use on this post
EditCannot edit other people's posts
ReplyReply to this post
EditCannot edit other people's posts
Rec (8)
ReplyReply to this post
5 replies
= new reply since forum marked as read
Highlight:
NoneDon't highlight anything
5 newestHighlight 5 most recent replies
Drug companies are sitting on generics--43% of recently approved aren't for sale (Original Post)
workinclasszero
Feb 2019
OP
Then that's where the government steps in and manufactures the drugs itself
workinclasszero
Feb 2019
#3
kacekwl
(7,017 posts)1. I'm sure trumps all over this travisty
as he said (lied) in the SOTU speech.
Wounded Bear
(58,660 posts)2. No money in generics...
They like the big sexy new stuff treating obscure shit nobody ever heard of rather than those boring generics that only keep people alive.
And no, it's not sarcasm, it's truth.
workinclasszero
(28,270 posts)3. Then that's where the government steps in and manufactures the drugs itself
for the benefit of the citizens of the country!
Well if the US government actually gave a shit about it's not 1%er population anyway.
Wounded Bear
(58,660 posts)4. I'm with you on that one...
MFA will probably devolve into a 'public option' if we can fight it out.
Any improvement in medical care is something I can support.
Drug prices are a huge part of the problem.
Andy823
(11,495 posts)5. I agree
But as long as trump is in office it won't happen. He will simply continue to lie to the people about how "concerned" he is about this, but do as the drug companies want him to do, nothing.